<DOC>
	<DOCNO>NCT01949974</DOCNO>
	<brief_summary>The purpose clinical trial compare non-pharmaceutical intervention ( Integral Attention Program PAI ) versus standard palliative chemotherapy treatment plus PAI patient advance cancer already receive least first course chemotherapy proven therapeutic failure . The study hypothesis palliative chemotherapy offer clear benefit relation quality-of-life-adjusted survival compare comprehensive care program .</brief_summary>
	<brief_title>Integral Attention Program With Without Palliative Chemotherapy Advanced Cancer Patients</brief_title>
	<detailed_description />
	<criteria>Men woman â‰¥18 year age . Patients potentially eligible receive new chemotherapy cycle whose clinical condition , accord oncologist , identify therapeutic strategy clearly superior another , light scientific evidence . Patients advance cancer treat chemotherapy display complete response treatment , treatment response , situation recurrence disease progression Patients previously receive least one chemotherapy cycle follow tumor : Cancer digestive gastrointestinal tract Head Neck Cancer Lung cancer Urologic cancer Gynecologic cancer Central nervous system cancer Melanoma Patients potentially comply study and/or monitoring procedure accept sign inform consent form . Patients whose home locate less 10 km , approximately , hospital participate study . Patients currently receive chemotherapy , although patient pursue concomitant treatment eligible ( eg , hormone therapy radiation therapy ) . Patients contraindication chemotherapy . Patients agree participate clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Palliative Chemotherapy</keyword>
	<keyword>Integral Attention Program</keyword>
	<keyword>Advanced cancer</keyword>
	<keyword>Randomized Clinical Trial</keyword>
</DOC>